Modulation of lymphokine-activated killer cell-mediated cytotoxicity by estradiol and tamoxifen
β Scribed by Edward Baral; Eva Nagy; Istvan Berczi
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 580 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
The effect of tamoxifen (TX) and estradiol (E2) on interleukin-2 (IL-2)-activated killer (LAK) cell-mediated cytotoxicity was examined using spleen cells of Fisher 344 rats as the source of effectors and P815 murine mastocytoma cells as targets.
Treatment of target cells with either TX or E2 for 4 or 18 hr rendered them highly sensitive to I A K cell-mediated lysis. When TX and E2 were applied jointly, cytotoxicity remained at the level of TX treatment alone. The cytotoxic potential of IL-2-primed LAK cells was not modified consistently by TX and
π SIMILAR VOLUMES
The presence of β£1,2-fucosylated glycans at the surface of rat colon carcinoma cells has been associated with an increased tumorigenicity and resistance to natural killer/lymphokine activated killer (NK/LAK) cytotoxicity. We now report that transfection of rat β£1,2-fucosyltransferases cDNA (FTA and
With the aim of developing an effective immunotherapy for malignant glioma, glioma cells were incubated with tumor necrosis factor-a (TNF-a) to increase their susceptibility to lysis by lymphokine-activated killer (LAK) cells. Treatment with exogenous TNF-a induced the expression of intercellular ad
## Abstract Development of inducible genetic switches for in vivo use with transgenic mice has revolutionized many areas in modern molecular biology. Combining two techniques, Cre/loxPβbased genetic recombination and ligandβdependent activation of a chimeric protein, we generated transgenic mice wh